Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,720 | 397 | 98.8% |
| Education | $68.03 | 6 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,563 | 146 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $794.01 | 45 | $0 (2020) |
| GlaxoSmithKline, LLC. | $434.13 | 25 | $0 (2020) |
| Lilly USA, LLC | $418.99 | 26 | $0 (2020) |
| Novo Nordisk Inc | $411.53 | 27 | $0 (2020) |
| Allergan, Inc. | $316.40 | 20 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $186.43 | 12 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $161.54 | 14 | $0 (2019) |
| AbbVie Inc. | $128.46 | 7 | $0 (2023) |
| Mylan Specialty L.P. | $114.63 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $42.65 | 2 | AbbVie Inc. ($42.65) |
| 2021 | $21.34 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($21.34) |
| 2020 | $534.93 | 33 | Boehringer Ingelheim Pharmaceuticals, Inc. ($134.94) |
| 2019 | $1,931 | 124 | Boehringer Ingelheim Pharmaceuticals, Inc. ($515.30) |
| 2018 | $1,554 | 110 | Boehringer Ingelheim Pharmaceuticals, Inc. ($399.14) |
| 2017 | $1,704 | 133 | Boehringer Ingelheim Pharmaceuticals, Inc. ($491.87) |
All Payment Transactions
403 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2023 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/03/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Diabetes | ||||||
| 11/05/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/16/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Diabetes | ||||||
| 09/09/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/17/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: IMMUNOLOGY | ||||||
| 02/12/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: RESPIRATORY | ||||||
| 02/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Respiratory | ||||||
| 02/06/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 01/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: RESPIRATORY | ||||||
| 01/29/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 30 | 30 | $6,450 | $775.16 |
| 2022 | 7 | 353 | 496 | $98,230 | $29,912 |
| 2021 | 14 | 612 | 811 | $125,860 | $42,792 |
| 2020 | 13 | 866 | 1,187 | $135,000 | $44,454 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 30 | $6,450 | $775.16 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 192 | $59,455 | $15,313 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 147 | $31,540 | $11,173 | 35.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 25 | 25 | $1,750 | $1,714 | 97.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,690 | $831.22 | 49.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 40 | 71 | $2,485 | $670.95 | 27.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $1,120 | $170.58 | 15.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 19 | $190.00 | $40.54 | 21.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 241 | $74,380 | $26,610 | 35.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 102 | 137 | $25,865 | $6,910 | 26.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 26 | 26 | $8,700 | $3,623 | 41.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 43 | 43 | $3,010 | $2,806 | 93.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 44 | 44 | $2,860 | $815.32 | 28.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 33 | 59 | $2,065 | $572.89 | 27.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 53 | 53 | $4,070 | $523.20 | 12.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 22 | $1,860 | $250.20 | 13.5% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 30 | 45 | $1,075 | $176.85 | 16.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 69 | 73 | $850.00 | $164.25 | 19.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2021 | 21 | 21 | $420.00 | $121.38 | 28.9% |
| 83986 | Body fluid ph level | Office | 2021 | 23 | 23 | $345.00 | $82.34 | 23.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 12 | 12 | $180.00 | $74.76 | 41.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 12 | 12 | $180.00 | $62.16 | 34.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 175 | 429 | $75,075 | $23,250 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 106 | 106 | $31,900 | $13,390 | 42.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 34 | 34 | $2,890 | $2,073 | 71.7% |
About Dr. Benjamin Weisman, M.D
Dr. Benjamin Weisman, M.D is a Specialist healthcare provider based in Bridgeport, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427053073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Weisman, M.D has received a total of $5,788 in payments from pharmaceutical and medical device companies, with $42.65 received in 2023. These payments were reported across 403 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,720).
As a Medicare-enrolled provider, Weisman has provided services to 1,861 Medicare beneficiaries, totaling 2,524 services with total Medicare billing of $117,933. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Geriatric Medicine, Pulmonary Disease
- Location Bridgeport, CT
- Active Since 06/20/2005
- Last Updated 03/07/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427053073
Products in Payments
- SPIRIVA RESPIMAT (Drug) $562.29
- FARXIGA (Drug) $439.35
- STIOLTO (Drug) $307.43
- OFEV (Drug) $284.70
- Ozempic (Drug) $275.11
- STIOLTO RESPIMAT (Drug) $245.77
- BASAGLAR (Drug) $162.00
- BREO (Drug) $154.69
- XARELTO (Drug) $136.60
- TRULICITY (Drug) $134.98
- VRAYLAR (Drug) $130.80
- NUCALA (Biological) $122.12
- JARDIANCE (Drug) $121.34
- SYMBICORT (Drug) $116.65
- JANUVIA (Drug) $110.92
- TRADJENTA (Drug) $107.38
- XIFAXAN (Drug) $106.74
- FASENRA (Drug) $100.20
- DUPIXENT (Biological) $78.87
- BYSTOLIC (Drug) $76.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Bridgeport
Alan Nelson, M.d, M.D
Specialist — Payments: $6,769
Dr. Shiv Navada, Md, MD
Specialist — Payments: $5,766
Marc Costa, Md, MD
Specialist — Payments: $5,539
Dr. Patrick Mastroianni, M.d, M.D
Specialist — Payments: $335.57
Richard Link, M.d, M.D
Specialist — Payments: $62.21
Zosimo Adefuin, Md, MD
Specialist — Payments: $14.17